This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vorona, E. Articles by Nieschlag, E. Search for Related Content PubMed PubMed Citation Articles by Vorona, E. Articles by Nieschlag, E. Pubmed/NCBI databases OMIM Genetics Home Reference Medline Plus Health Information Klinefelter's Syndrome Related Collections Male Endocrinology

Clinical, Endocrinological, and Epigenetic Features of the 46,XX Male Syndrome, Compared with 47,XXY Klinefelter Patients

Institute of Reproductive Medicine (E.V., M.Z., J.G., E.N.) and Department of Obstetrics and Gynecology (A.N.S.), University Clinics of Münster, D-48129 Münster, Germany

Address all correspondence and requests for reprints to: Eberhard Nies-chlag, Institute of Reproductive Medicine of the University, Domagkstrasse 11, D-48129 Münster, Germany. E-mail: eberhard.nieschlag{at}ukmuenster.de.

Context: The 46,XX male syndrome represents a rare, poorly characterized form of male hypogonadism.

Objective: The objective of the study was to distinguish the 46,XX male syndrome from the more frequent 47,XXY-Klinefelter syndrome in regard to clinical, hormonal, and epigenetic features.

Design: This was a case-control study.

Setting: The study was conducted at a university-based reproductive medicine and andrology institution.

Patients: Eleven SRY-positive 46,XX males were compared with age-matched controls: 101 47,XXY Klinefelter patients, 78 healthy men, and 157 healthy women [latter all heterozygous for androgen receptor (AR) alleles].

Interventions: There were no interventions.

Main Outcome Measures: There was a comparison of phenotype, endocrine profiles, and X-chromosomal inactivation patterns of AR alleles.

Results: The 46,XX males were significantly smaller than Klinefelter patients or healthy men, resembling female controls in height and weight. The incidence of maldescended testes was significantly higher than that in Klinefelter patients and controls. Gynecomastia was more frequent in comparison with controls, whereas there was a nonsignificant trend in comparison with Klinefelter patients. All XX males were infertile and most were hypogonadal. The inactivation patterns of AR alleles in XX males were significantly more skewed than in Klinefelter patients and women. Seven of 10 heterozygous XX male patients displayed an extreme skewing of more than 80% with no preference toward the shorter or longer AR allele. The length of the AR CAG repeat polymorphism was positively related to traits of hypogonadism.

Conclusions: XX males are distinctly different from Klinefelter patients in terms of clinical and epigenetic features. Nonrandom X chromosome inactivation ratios are common in XX males, possibly due to the translocated SRY gene. The existence of a Y-chromosomal, growth-related gene is discussed.

This article has been cited by other articles:

				C. Foresta, D. Zuccarello, A. Garolla, and A. Ferlin Role of Hormones, Genes, and Environment in Human Cryptorchidism Endocr. Rev., August 1, 2008; 29(5): 560 - 580. [Abstract] [Full Text] [PDF]

				L. Aksglaede, R. B. Jensen, E. Carlsen, P. Kok, D. M Keenan, J. Veldhuis, N. E Skakkebaek, and A. Juul Increased basal and pulsatile secretion of FSH and LH in young men with 47,XXY or 46,XX karyotypes. Eur. J. Endocrinol., June 1, 2008; 158(6): 803 - 810. [Abstract] [Full Text] [PDF]

				L. Aksglaede, N. E. Skakkebaek, and A. Juul Abnormal Sex Chromosome Constitution and Longitudinal Growth: Serum Levels of Insulin-Like Growth Factor (IGF)-I, IGF Binding Protein-3, Luteinizing Hormone, and Testosterone in 109 Males with 47,XXY, 47,XYY, or Sex-Determining Region of the Y Chromosome (SRY)-Positive 46,XX Karyotypes J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 169 - 176. [Abstract] [Full Text] [PDF]